Identification of RGS2 and type V adenylyl cyclase interaction sites - Wikidata - wikimedia - TriplyDB

Identification of RGS2 and type V adenylyl cyclase interaction sites

Identification of RGS2 and type V adenylyl cyclase interaction sites

http://www.wikidata.org/entity/Q28211957

about

sameAs

Gq/11-mediated signaling and hypertrophy in mice with cardiac-specific transgenic expression of regulator of G-protein signaling 2 Conditional stimulation of type V and VI adenylyl cyclases by G protein betagamma subunits Deregulation of RGS2 in cardiovascular diseases Regulation of type V adenylate cyclase by Ric8a, a guanine nucleotide exchange factor Regulator of G Protein Signaling 2: A Versatile Regulator of Vascular Function Regulators of G-protein signaling in the heart and their potential as therapeutic targets.Decreased striatal RGS2 expression is neuroprotective in Huntington's disease (HD) and exemplifies a compensatory aspect of HD-induced gene regulation Tempol treatment reduces anxiety-like behaviors induced by multiple anxiogenic drugs in rats The A-kinase anchoring protein Yotiao binds and regulates adenylyl cyclase in brain CRTC3 links catecholamine signalling to energy balance Structure of the Regulator of G Protein Signaling 8 (RGS8)-Gαq Complex: MOLECULAR BASIS FOR Gα SELECTIVITY.The evolution of regulators of G protein signalling proteins as drug targets - 20 years in the making: IUPHAR Review 21.Phosphoproteome and transcriptome analysis of the neuronal response to a CDK5 inhibitor.Non-canonical functions of RGS proteins RGS2 is a feedback inhibitor of melatonin production in the pineal gland.Enhanced cardiac function in Gravin mutant mice involves alterations in the β-adrenergic receptor signaling cascade Regulator of G protein signaling 2 (RGS2) and RGS4 form distinct G protein-dependent complexes with protease activated-receptor 1 (PAR1) in live cells.β2-Adrenoceptor agonist-induced RGS2 expression is a genomic mechanism of bronchoprotection that is enhanced by glucocorticoids How regulators of G protein signaling achieve selective regulation.A newly identified complex of spinophilin and the tyrosine phosphatase, SHP-1, modulates platelet activation by regulating G protein-dependent signaling.Regulation of Smad-mediated gene transcription by RGS3.Adenylyl Cyclase 5 Regulation by Gβγ Involves Isoform-Specific Use of Multiple Interaction Sites.Comparative electrostatic analysis of adenylyl cyclase for isoform dependent regulation properties.Cardiotonic steroids stabilize regulator of G protein signaling 2 protein levels The A-kinase anchoring protein Yotiao facilitates complex formation between adenylyl cyclase type 9 and the IKs potassium channel in heart.R4 RGS proteins: regulation of G-protein signaling and beyond.The complex of G protein regulator RGS9-2 and Gβ(5) controls sensitization and signaling kinetics of type 5 adenylyl cyclase in the striatum Hypertension in mice with transgenic activation of the brain renin-angiotensin system is vasopressin dependent Digoxin-Mediated Upregulation of RGS2 Protein Protects against Cardiac Injury.Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies.Translational control by RGS2.N terminus of type 5 adenylyl cyclase scaffolds Gs heterotrimer.Functional role, mechanisms of regulation, and therapeutic potential of regulator of G protein signaling 2 in the heart.Unanticipated signaling events associated with cardiac adenylyl cyclase gene transfer.Regulators of G protein signaling: role in hematopoiesis, megakaryopoiesis and platelet function.Adenylate cyclase-centred microdomains.The impact of RGS and other G-protein regulatory proteins on Gαi-mediated signaling in immunity.RGS2 regulates urotensin II-induced intracellular Ca2+ elevation and contraction in glomerular mesangial cells.International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.Chronic adrenaline treatment fails to down-regulate the Del301-303-alpha2B-adrenoceptor in neuronal cells.

P2860

Q21134156-32249D0A-5C43-464A-927B-FA38C8BB9CA3 Q24316413-A0239995-3B47-4EF4-9DCC-785589BF30F0 Q24654920-1DA92913-A9C4-4AAD-8F05-C9E676AECF91 Q24670133-D99E74D2-822D-4AC7-9715-978F736C0BBF Q26823214-B111960B-AE13-4357-8916-DE6ED2D70143 Q27686777-F98BA758-71BF-4824-B82E-4EA99D51939B Q28479035-381AEB09-476F-424A-87BE-65F9C063BF8A Q28544733-18668764-D330-400C-B6F7-2B8A2430F881 Q28582665-D6D786C3-523B-4C42-A2BA-F0D4CD23A780 Q29144914-83317CBC-5E63-4784-8CBE-DA0F870415AC Q30383436-A8EE8B90-E454-4BEA-8646-8EC9147B046A Q30397640-B6F2C9B1-F3FE-49E6-A469-67DCBE8CD14C Q31147426-422D2080-6D69-4917-BE0E-7575CC89E1A6 Q33945560-485A71C4-98D7-4F97-B2F2-D93DBB873E27 Q33993328-26661F3E-B48C-4C97-81AD-C77CB3F2C64D Q34994899-4A7CD705-127C-46C7-8453-E8F178E8579D Q35151830-80F3ECC6-8768-43EB-B291-B1F0882F91A1 Q35621371-71D4D35D-6C18-4DC1-969A-398947D29411 Q35652043-73AF4631-49DF-4BC0-8E81-636C995E100B Q35802247-27578A91-25C0-4F0E-AB24-822E13128C24 Q35898443-E5AFD97D-305F-4AB5-9863-CB2F5D5E6D7B Q36077736-8D203035-7F91-4D3E-93B0-EDE68F12AEE0 Q36144310-254E0864-FFB1-4DF2-B9BC-597732DB6EB6 Q36174768-5C47625B-FE56-4964-B708-49B9A393037D Q36215999-16CC7107-E1BE-42DB-8DDF-9AC1AA2449F0 Q36301542-CD781704-D311-4C54-9132-61E21D10FC58 Q36634572-66FDA802-4854-4493-8831-84991771F533 Q36838219-10289715-E77E-41D2-9C08-1782D0139FA9 Q36852562-1C0112D9-0EFE-4725-B207-79BC540D6E8C Q37307356-C4546D68-00C8-44B2-B635-530991CB90F7 Q37342462-F6E0866F-75A5-4C95-94C7-1D737153977E Q37444511-D9B006C3-633C-4426-8566-0A955798D587 Q37627848-4C5555F1-F46A-4F63-A7EC-3CC045CF5884 Q37847462-788F3A46-E94E-4755-975E-E714BAE042DA Q38036343-1007B6AF-90AF-42EA-979E-F3C0271FAC82 Q38237737-D7D62B09-8E75-4592-9EAE-5963BC9E6B6E Q38806373-74716CD9-EE3E-49B0-AAB9-41FAE633DA63 Q39084425-8A4F333F-39CD-4478-AFCE-AE762539EB6F Q39158851-325AFD21-A46B-42BC-885D-815FBB8CB444 Q39806031-6BCC8524-39E1-4123-9C55-A456E0BD32DE

P2860

Identification of RGS2 and type V adenylyl cyclase interaction sites

http://www.wikidata.org/entity/Q28211957

description

2003 nî lūn-bûn

@nan

2003 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Identification of RGS2 and type V adenylyl cyclase interaction sites

@ast

Identification of RGS2 and type V adenylyl cyclase interaction sites

@en

Identification of RGS2 and type V adenylyl cyclase interaction sites

@nl

type

label

Identification of RGS2 and type V adenylyl cyclase interaction sites

@ast

Identification of RGS2 and type V adenylyl cyclase interaction sites

@en

Identification of RGS2 and type V adenylyl cyclase interaction sites

@nl

prefLabel

Identification of RGS2 and type V adenylyl cyclase interaction sites

@ast

Identification of RGS2 and type V adenylyl cyclase interaction sites

@en

Identification of RGS2 and type V adenylyl cyclase interaction sites

@nl

P1433

Q28211957-E48297E3-913D-40F9-A089-71C4970C1F1E

P1476

Q28211957-978FA972-14EA-497E-92AA-AA0D6CBF9A3B

P2093

Q28211957-2FF105F8-0C8F-432D-B4AD-46F75B1BF9EC

Q28211957-6D5523AD-53F9-4875-B336-2F3F7C58E0C3

Q28211957-8E9ED04D-1BEC-4EFD-BD95-1A8A6734D791

Q28211957-F0EBE181-1A1F-46CB-AC51-506170C10FFE

P2860

Q28211957-17DC759A-4CC7-4750-A1CF-C69A8294A7C7

Q28211957-1C1A4E3F-6A9F-456D-8310-E9F0D0490D84

Q28211957-243D7BAE-6BC7-49A4-8851-3622B3B1E05C

Q28211957-359E461A-AA9A-4E4A-995F-70831EC85169

Q28211957-3A6CBC27-1152-4115-B07E-1EF044A1ECC5

Q28211957-3FCA6A7A-37A2-4F30-AA6B-FC60A8EAEA82

Q28211957-43F4EE99-9A9B-491A-AA85-E773DD605971

Q28211957-47A3F2F8-0591-46B1-95D4-CAE923384F4D

Q28211957-53E709C3-9B64-421B-B7B5-110A5BEEF1C7

Q28211957-56B1BC99-457F-4B2B-9C16-A38FD61522C7

P304

Q28211957-35C4F07B-4BF4-474E-A0B0-460FE87B69AB

P31

Q28211957-1A4B758B-2C64-440E-BCE8-85F83A32A948

P356

Q28211957-2A84CE1D-0C45-430F-B6C4-B9327B36D0D0

P407

Q28211957-B1B69892-B383-4498-9BA8-BB8C581207D3

P433

Q28211957-CA887A3B-4B72-41E5-8539-E9C1A7DCA5ED

P478

Q28211957-1D73C918-A2FC-4BBE-BA3E-CAB360FC630C

P577

Q28211957-A66400AF-42FE-453F-B7B1-97E0943D08FD

P698

Q28211957-4312024E-8720-4215-B656-49353D475E0B

P356

P1433

Journal of Biological Chemistry

P1476

Identification of RGS2 and type V adenylyl cyclase interaction sites

@en

P2093

Carmen W Dessauer

http://www.w3.org/2001/XMLSchema#string

John H Kehrl

http://www.w3.org/2001/XMLSchema#string

Samina Salim

http://www.w3.org/2001/XMLSchema#string

Srikumar Sinnarajah

http://www.w3.org/2001/XMLSchema#string

P2860

RGS3 inhibits G protein-mediated signaling via translocation to the membrane and binding to Galpha11

RGS-PX1, a GAP for GalphaS and sorting nexin in vesicular trafficking

Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family

RGS4 and RGS2 bind coatomer and inhibit COPI association with Golgi membranes and intracellular transport

Interaction of the two cytosolic domains of mammalian adenylyl cyclase

Identification, expression, and crystallization of the protease-resistant conserved domain of synapsin I

Structure of RGS4 bound to AlF4--activated G(i alpha1): stabilization of the transition state for GTP hydrolysis

Mechanisms governing subcellular localization and function of human RGS2

Modulation of the affinity and selectivity of RGS protein interaction with G alpha subunits by a conserved asparagine/serine residue

Regulator of G protein signaling RGS3T is localized to the nucleus and induces apoptosis

P304

15842-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M210663200

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

278

http://www.w3.org/2001/XMLSchema#string

P577

2003-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12604604

http://www.w3.org/2001/XMLSchema#string